Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication

ABSTRACT The VP35 protein of Zaire Ebola virus is an essential component of the viral RNA polymerase complex and also functions to antagonize the cellular type I interferon (IFN) response by blocking activation of the transcription factor IRF-3. We previously mapped the IRF-3 inhibitory domain within the C terminus of VP35. In the present study, we show that mutations that disrupt the IRF-3 inhibitory function of VP35 do not disrupt viral transcription/replication, suggesting that the two functions of VP35 are separable. Second, using reverse genetics, we successfully recovered recombinant Ebola viruses containing mutations within the IRF-3 inhibitory domain. Importantly, we show that the recombinant viruses were attenuated for growth in cell culture and that they activated IRF-3 and IRF-3-inducible gene expression at levels higher than that for Ebola virus containing wild-type VP35. In the context of Ebola virus pathogenesis, VP35 may function to limit early IFN-β production and other antiviral signals generated from cells at the primary site of infection, thereby slowing down the host's ability to curb virus replication and induce adaptive immunity.

[1]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[2]  Tokiko Watanabe,et al.  Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics , 2004, Journal of Virology.

[3]  Stephan Becker,et al.  Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems , 1999, Journal of Virology.

[4]  A. Rowe,et al.  Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[5]  S. Nichol,et al.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.

[6]  C. Goldsmith,et al.  Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. , 2005, Virology.

[7]  J. Mosca,et al.  Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis , 1986, Molecular and cellular biology.

[8]  C. Basler,et al.  Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. , 2005, Virology.

[9]  P. Jahrling,et al.  Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. , 2003, The Journal of infectious diseases.

[10]  A. Sanchez,et al.  The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.

[11]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.

[12]  M. Bray,et al.  Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. , 2001, Journal of comparative pathology.

[13]  J. Hiscott,et al.  Essential Role of Interferon Regulatory Factor 3 in Direct Activation of RANTES Chemokine Transcription , 1999, Molecular and Cellular Biology.

[14]  M. Bray,et al.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. , 1998, The Journal of infectious diseases.

[15]  E. Mühlberger,et al.  A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. , 2005, Virology.

[16]  M. Bray,et al.  Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. , 2005, The international journal of biochemistry & cell biology.

[17]  M. Horzinek.  Molecular pathogenesis of virus infections , 1987, Experientia.

[18]  G. Ruthel,et al.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. , 2003, The Journal of infectious diseases.

[19]  B. Pulendran,et al.  Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.

[20]  M. Bray,et al.  Ebola hemorrhagic fever and septic shock. , 2003, The Journal of infectious diseases.

[21]  H. Klenk,et al.  Three of the Four Nucleocapsid Proteins of Marburg Virus, NP, VP35, and L, Are Sufficient To Mediate Replication and Transcription of Marburg Virus-Specific Monocistronic Minigenomes , 1998, Journal of Virology.

[22]  P. Jahrling,et al.  Pathogenesis of experimental Ebola virus infection in guinea pigs. , 1999, The Journal of infectious diseases.

[23]  C. Goldsmith,et al.  Pathologic features of filovirus infections in humans. , 1999, Current topics in microbiology and immunology.

[24]  R. Ahmed,et al.  Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in Vitro , 2001 .

[25]  P. Jahrling,et al.  ELISA for the detection of antibodies to Ebola viruses. , 1999, The Journal of infectious diseases.

[26]  H. Klenk,et al.  Interactions of Marburg virus nucleocapsid proteins. , 1998, Virology.

[27]  J. Hiscott,et al.  The interferon antiviral response: from viral invasion to evasion , 2002, Current opinion in infectious diseases.

[28]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[29]  V. Volchkov,et al.  The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Mühlberger,et al.  The Ebola Virus Genomic Replication Promoter Is Bipartite and Follows the Rule of Six , 2005, Journal of Virology.

[31]  B. Pulendran,et al.  Impairment of dendritic cells and adaptive immunity by Ebola and lassa viruses , 2003 .

[32]  S. Becker,et al.  Co- and posttranslational modifications and functions of Marburg virus proteins. , 1999, Current topics in microbiology and immunology.

[33]  S. Finke,et al.  Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.

[34]  H. Klenk,et al.  Homo-Oligomerization of Marburgvirus VP35 Is Essential for Its Function in Replication and Transcription , 2005, Journal of Virology.

[35]  Stuart T. Nichol,et al.  Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome , 2004, Journal of Virology.

[36]  A. García-Sastre,et al.  A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice , 2003, Journal of Virology.

[37]  M. Barro,et al.  Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Randall,et al.  Pathogenesis of Ebola and Marburg viruses. , 2005 .

[39]  R. Ahmed,et al.  Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. , 2001, Virology.

[40]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[41]  H. Klenk,et al.  Phosphorylation of VP30 Impairs Ebola Virus Transcription* , 2002, The Journal of Biological Chemistry.

[42]  J. Hiscott,et al.  Regulation of RANTES Chemokine Gene Expression Requires Cooperativity Between NF-κB and IFN-Regulatory Factor Transcription Factors1 , 2000, The Journal of Immunology.

[43]  M. Bray,et al.  Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. , 2001, Journal of comparative pathology.

[44]  E. Ryabchikova,et al.  An analysis of features of pathogenesis in two animal models of Ebola virus infection. , 1999, The Journal of infectious diseases.

[45]  J. McCormick,et al.  Descriptive analysis of Ebola virus proteins. , 1985, Virology.